Salvage concurrent radio-chemotherapy for post-operative local recurrence of squamous-cell esophageal cancer

Radiation Oncology

Volumn 7, Issue 1, 2012, Pages

  Zhang, Jian ^a   Peng, Feng ^a   Li, Na ^b   Liu, Yongmei ^a   Xu, Yong ^a   Zhou, Lin ^a   Wang, Jin ^a   Zhu, Jiang ^a   Huang, Meijuan ^a   Gong, Youling ^a  

^a SICHUAN UNIVERSITY   (China)

^b ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Post operative local recurrence; Salvage radio chemotherapy; Squamous cell esophageal cancer; Toxicity; Treatment outcomes

Indexed keywords

CISPLATIN; FLUOROURACIL; PACLITAXEL;

ADULT; ANEMIA; ARTICLE; CANCER RECURRENCE; CANCER SURVIVAL; CHEMORADIOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; DIARRHEA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGITIS; ESOPHAGUS RESECTION; FEMALE; FOLLOW UP; GASTRITIS; HUMAN; MALE; NAUSEA AND VOMITING; NEUTROPENIA; OVERALL SURVIVAL; POSTOPERATIVE COMPLICATION; PROGRESSION FREE SURVIVAL; RADIATION DOSE; RETROSPECTIVE STUDY; SALVAGE THERAPY; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; UNIVARIATE ANALYSIS;

ADULT; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; CISPLATIN; DISEASE-FREE SURVIVAL; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PACLITAXEL; RETROSPECTIVE STUDIES; SALVAGE THERAPY; TREATMENT OUTCOME;

EID: 84862303238     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-7-93     Document Type: Article

References (29)

1. Fujita H, Kakegawa T, Yamana H, Shima I, Toh Y, Tomita Y, Fujii T, Yamasaki K, Higaki K, Noake T. Mortality and morbidity rates, post-operative course, quality of life, and prognosis after extended radical lymphadenectomy for esophageal cancer. Ann Surg 1995, 222:654-662.
2. Akiyama H, Tsurumaru M, Udagawa H, Kajiyama Y. Radical lymph node dissection for cancer of the thoracic esophagus. Ann Surg 1994, 220:364-373.
3. Ando N, Oazawa S, Kitagawa Y, Shinozawa Y, Kitajima M. Improvement in the results of treatment of advanced squamous esophageal carcinoma over fifteen consecutive years. Ann Surg 2000, 232:225-232.
4. Bhansali MS, Fujita H, Kakegawa T, Yamana H, Ono T, Hikita S, Toh Y, Fujii T, Tou U, Shirouzu K. Pattern of recurrence after extended radical esophagectomy with three-field lymph node dissection for squamous cell carcinoma in the thoracic esophagus. World J Surg 1997, 21:275-281.
5. Kyriazanos ID, Tachibana M, Shibakita M, Yoshimura H, Kinugasa S, Dhar DK, Nakamoto T, Fujii T, Nagasue N. Pattern of recurrence after extended esophagectomy for squamous cell carcinoma of the esophagus. Hepatogastroenterology 2003, 50:115-120.
6. Raoul JL, Le Prise E, Meunier B, Julienne V, Etienne PL, Gosselin M, Launois B. Combined radiochemotherapy for postoperative recurrence of oesophageal cancer. Gut 1995, 37:174-176.
7. Sato N, Ishida K, Ikeda K, Koeda K, Ohtsuka K, Kimura Y, Aoki K, Ogasawara S, Iwaya T, Saito K. Treatment of patients with recurrent esophageal carcinoma. Gan To Kagaku Ryoho 1998, 25:314-320.
8. Nemoto K, Ariga H, Kakuto Y, Matsushita H, Takeda K, Takahashi C, Takai Y, Yamada S, Hosoi Y. Radiation therapy for loco-regionally recurrent esophageal cancer after surgery. Radiother Oncol 2001, 61:165-168.
9. Urba SG, Chansky K, Van Veldhuizen PJ, Pluenneke RE, Benedetti JK, Macdonald JS, Abbruzzese JL, . Southwest Oncology Group Study Gemcitabine and Cisplatin for patients with metastatic or recurrent esophageal carcinoma: A Southwest Oncolgy Group study. Invest New Drugs 2004, 2:91-97. Southwest Oncology Group Study.
10. Fahn HJ, Wang LS, Huang BS, Huang MH, Chien KY. Tumor recurrence in long-term survivors after treatment of carcinoma of the esophagus. Ann Thorac Surg 1994, 57:677-681.
11. Airoldi M, Cortesina G, Giordano C, Pedani F, Bumma C, Gabriele P. Docetaxel and vinorelbine: an effective regimen in recurrent squamous cell esophageal carcinoma. Med Oncol 2003, 20:19-24.
12. Nemoto K, Matsushita H, Ogawa Y, Takeda K, Takahashi C, Britton KR, Takai Y, Miyazaki S, Miyata T, Yamada S. Radiation therapy combined with cis-diammine-glycolatoplatinum (Nedaplatin) and 5-fluorouracil for untreated and recurrent esophageal cancer. Am J Clin Oncol 2003, 26:46-49.
13. Yamashita H, Nakagawa K, Tago M, Nakamura N, Shiraishi K, Ohtomo K. Salvage radiotherapy for postoperative loco-regional recurrence of esophageal cancer. Dis Esophagus 2005, 18:215-220.
14. Shioyama Y, Nakamura K, Ohga S, Nomoto S, Sasaki T, Yamaguchi T, Toba T, Yoshitake T, Terashima H, Honda H. Radiation therapy for recurrent esophageal cancer after surgery: clinical results and prognostic factors. Jpn J Clin Oncol 2007, 37:918-923.
15. Baxi SH, Burmeister B, Harvey JA, Smithers M, Thomas J. Salvage definitive chemo-radiotherapy for locally recurrent oesophageal carcinoma after primary surgery: retrospective review. J Med Imag Radiat Oncol 2009, 52:583-587.
16. Nakamura T, Ota M, Narumiya K, Sato T, Ohki T, Yamamoto M, Mitsuhashi N. Multimodal treatment for lymph node recurrence of esophageal carcinoma after curative resection. Ann Surg Oncol 2008, 15:2451-2457.
17. Jingu K, Nemoto K, Matsushita H, Takahashi C, Ogawa Y, Sugawara T, Nakata E, Takai Y, Yamada S. Results of radiation therapy combined with nedaplatin (cis-diammine-glycoplatinum) and 5-Fluorouracil for postoperative locoregional recurrent esophageal cancer. BMC Cancer 2006, 6:50.
18. Clinical Practice Guidelines in Oncology Esophageal cancer. NCCN guidelines version 1 2009, , , www.NCCN.org, Clinical Practice Guidelines in Oncology.
19. World Medical Association Declaration of Helsinki. Bull World Health Organ 2001, 79:373-374. World Medical Association.
20. AJCC Cancer Staging Manual American Joint Committee on Cancer 2002, Springer-Verlag, New York, 6, AJCC Cancer Staging Manual.
21. Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, Verweij J, Van Glabbeke M, van Oosterom AT, Christian MC, Gwyther SG. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000, 92:205-216.
22. Ajani JA, Winter K, Komaki R, Kelsen DP, Minsky BD, Liao ZX, Bradley J, Fromm M, Hornback D, Willett CG. Phase II randomized trial of two nonoperative regimens of induction chemotherapy followed by chemoradiation in patients with localized carcinoma of the esophagus: RTOG 0113. J Clin Oncol 2008, 26:4551-4556.
23. Minsky BD, Pajak TF, Ginsberg RJ, Pisansky TM, Martenson J, Komaki R, Okawara G, Rosenthal SA, Kelsen DP. INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. J Clin Oncol 2002, 20:1167-1174.
24. Emami B, Lyman J, Brown A, Coia L, Goitein M, Munzenrider JE, Shank B, Solin LJ, Wesson M. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 1991, 21:109-122.
25. Ohtsu A, Boku N, Muro K, Chin K, Muto M, Yoshida S, Satake M, Ishikura S, Ogino T, Miyata Y, Seki S, Kaneko K, Nakamura A. Definitive chemoradiotherapy for T4 and/or M1 lymph node squamous cell carcinoma of the esophagus. J Clin Oncol 1999, 17:2915-2921.
26. Ishida K, Ando N, Yamamoto S, Ide H, Shinoda M. Phase II study of cisplatin and 5-fluorouracil with concurrent radiotherapy in advanced squamous cell carcinoma of the esophagus: a Japan Esophageal Oncology Group (JEOG)/Japan Clinical Oncology Group Trial (JCOG9516). Jpn J Clin Oncol 2004, 34:615-619.
27. Cooper JS, Guo MD, Herskovic A, Macdonald JS, Martenson JA, Al-Sarraf M, Byhardt R, Russell AH, Beitler JJ, Spencer S, Asbell SO, Graham MV, Leichman LL. Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group. J Am Med Assoc 1999, 281:1623-1627.
28. Urschel JD, Vasan H. A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer. Am J Surg 2003, 185:538-543.
29. Fiorica F, Di Bona D, Schepis F, Licata A, Shahied L, Venturi A, Falchi AM, Craxì A, Cammà C. Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis. Gut 2004, 53:925-930.